Concepedia
Statistics
Publications
29
Citations
1.9K
H-Index
23
Active since
1999
Affiliations
Bristol-Myers Squibb (United States)(Current)
Bristol-Myers Squibb (Germany)
University of North Carolina at Chapel Hill
University of Southern California
Jinan University
Feng Luo is an author at Bristol-Myers Squibb (United States) specializing in medicine, cancer research, and pharmacology.
Top concepts
MedicinePharmacologyCancer ResearchOncologyCell BiologyTumor BiologyRadiation OncologyCancer BiologyCancer Cell BiologyPathology
Publications per year
1999–2022
Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma
Anna Luisa Di Stefano, Alessandra Fucci, Veroniquè Frattini et al. · Clinical Cancer Research · 2015 · 266 citations
Oncologic Imaging, Idh Wild-type Glioma, Pathology +19
Dasatinib (BMS-354825) Pharmacokinetics and Pharmacodynamic Biomarkers in Animal Models Predict Optimal Clinical Exposure
Feng Luo, Zheng Yang, Amy Camuso et al. · Clinical Cancer Research · 2006 · 149 citations
Ovarian Epithelial Tumor Growth Promotion by Follicle-Stimulating Hormone and Inhibition of the Effect by Luteinizing Hormone
Wenxin Zheng, Jean Lu, Feng Luo et al. · Gynecologic Oncology · 2000 · 139 citations
Endocrine-related Cancer, Follicle-stimulating Hormone, Gynecology +9
Intestinal Transport of Irinotecan in Caco-2 Cells and MDCK II Cells Overexpressing Efflux Transporters Pgp, cMOAT, and MRP1
Feng Luo, Pankaj V. Paranjpe, Ailan Guo et al. · Drug Metabolism and Disposition · 2002 · 116 citations
Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway
Xuefang Wu, Feng Luo, Jinbang Li et al. · International Journal of Oncology · 2016 · 106 citations · Full text
Pathology, Cell Death, Aberrant Wnt +16
1–5 of 29